Biosimilars Market Size, Share, Trends & Growth 2033
The Global Biosimilars Market is emerging as a vital component of the pharmaceutical industry as healthcare providers seek affordable alternatives to high-cost biological therapies. The market was valued at USD 25.5 billion in 2023 and is anticipated to reach USD 117.9 billion by 2033 , registering a CAGR of 16.5% during the forecast period . Growing demand for accessible treatment options, expanding applications of biologic medicines, and increasing competition following patent expirations are encouraging manufacturers to strengthen their biosimilar development capabilities. Biosimilars are biological medicinal products developed to closely resemble previously authorized reference biologics. They undergo rigorous assessments to demonstrate that there are no clinically meaningful differences in quality, safety, and effectiveness compared with their reference products. Unlike traditional generic medicines, biosimilars involve complex biological manufacturing processes, specialized ana...